Mutations in the CPT2 gene cause carnitine palmitoyltransferase 2 deficiency. Mutations in the CPT2 gene lead to the production of a defective version of an enzyme called carnitine palmitoyltransferase 2. Together with carnitine, this enzyme helps release long-chain fatty acids from a particular transport enzyme.
If carnitine palmitoyltransferase 2 is defective, long-chain fatty acids from food and fats stored in the body cannot be broken down and processed. As a result, these fatty acids are not converted into energy, which can lead to characteristic signs and symptoms of this disorder, such as myalgia, weakness, and hypoglycemia. Excess long-chain fatty acids may build up in tissues, damaging the heart, liver, and muscles and causing more serious complications.
Read more about the CPT2 gene. More.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.